MedPath

Theralase Technologies Inc

Theralase Technologies Inc logo
🇨🇦Canada
Ownership
-
Employees
15
Market Cap
-
Website
Introduction

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Phase 2
Recruiting
Conditions
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Interventions
Combination Product: Ruvidar® (TLD-1433) Bladder infusion and PDT
First Posted Date
2019-05-10
Last Posted Date
2023-05-01
Lead Sponsor
Theralase® Technologies Inc.
Target Recruit Count
125
Registration Number
NCT03945162
Locations
🇨🇦

Site 01-001 - University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, Canada

🇺🇸

Site 02-012 - University of Chicago, Chicago, Illinois, United States

🇺🇸

Site 02-008 - MidLantic Urology, Bala-Cynwyd, Pennsylvania, United States

and more 9 locations

Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Phase 1
Completed
Conditions
Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
Interventions
Drug: TLD1433 infusion and photodynamic therapy (PDT) treatment
First Posted Date
2017-02-15
Last Posted Date
2018-08-20
Lead Sponsor
Theralase® Technologies Inc.
Target Recruit Count
6
Registration Number
NCT03053635
Locations
🇨🇦

University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath